 |
Европейская академия
|
| В начало | Энциклопедия ЕАЕН | |
Энциклопедия Европейской академии естественных наук |
||
Yue Gao
Yue Gao, female, Hans, born in December 1963 in Yixing (Jiangsu), graduated from Tianjin College of Traditional Chinese Medicine majoring in internal medicine, graduate degree, bachelor of science, doctoral degree in biochemistry and molecular biology. She is currently a researcher and doctoral supervisor of the Institute of Radiation Medicine of the Academy of Military Medical Sciences, and the director of the PLA Key Laboratory of Special Needs Traditional Chinese Medicine and Natural Medicine. She is also the chairman of the Chinese Medicine Toxicology and Safety Research Branch of the Chinese Association of Chinese Medicine, and the chairman of the Clinical Pharmacology and Toxicology Professional Committee of the Chinese Society of Integrative Medicine.
She has presided over a number of projects such as the National Natural Science Foundation of China, the national "973" project, and the military's special special project for the confidentiality of new drugs. In response to the urgent needs of the construction of nuclear radiation emergency medical rescue system, she innovatively developed a variety of anti-radiation drugs such as chemical drugs Class 1.1 with clear targets, and formed systematic research results, and obtained 6 new drug certificates and clinical approvals for special drugs needed by the military. In view of the technical bottleneck of TCM safety research, she took the lead in creating an advanced supporting key technology platform for TCM safety research, forming a new technical system for TCM safety evaluation, and successfully used in the confirmation of toxic components of TCM, analysis of toxicity mechanism, classical theoretical evidence, and innovative drug research and development. She systematically revealed the material basis, metabolic characteristics, contraindications and toxicity mechanism of toxicity of Chinese medicines in seven categories of common adverse reactions. She empirically proved the classical theory of contraindications in the formulation of Chinese medicines, and promoted the innovative development of the discipline of molecular toxicology of traditional Chinese medicines. She created a new method based on the combination of "formula-evidence" of traditional Chinese medicine in the study of systems biology, and opened up a new field of modern pharmacology research on traditional Chinese medicine compounds.
In 2013, her achievements in "Research and Application of Key Technologies for the Safety of Traditional Chinese Medicine" won the first prize of the National Science and Technology Progress Award. At present, she has won the first prize of the National Science and Technology Progress Award, the second prize of the National Science and Technology Progress Award, and the first prize of the Military Science and Technology Progress Award as the first completer. She has edited and published 2 monographs, obtained 10 Chinese invention patents, including 2 national defense patents, and published more than 232 papers, including 83 SCI papers. Her papers have a total citation of 4650 times. She has successively won the "National Outstanding Contribution Award of Traditional Chinese Medicine", academician of the International Eurasian Academy of Sciences, the first batch of winners of the National Innovation Competition Award, Wu Jieping Pharmaceutical Innovation Award, National Outstanding Scientific and Technological Worker, Wuzhou Women's Science and Technology Award, and the Special Contribution Award for the Academic Development of Chinese Medicine of the Chinese Association of Chinese Medicine.
More information about Yue Gao
| Yin Zongjun | Энциклопедия ЕАЕН | Zhang Jun |